Clinical trials sponsored by St. Jude Children's Research Hospital

Phase breakdown

Conditions studied

Recruiting trials led by St. Jude Children's Research Hospital

• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
  NCT04897321 · Phase: Phase 1 · Ages: Up to 21 Years · Sex: All (male and female) · 1 location
• Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
  NCT03353584 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Years to 25 Years · Sex: All (male and female) · 2 locations
• Familial Investigations of Childhood Cancer Predisposition
  NCT03050268 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Functional Ovarian Reserve in Sickle Cell Disease
  NCT07392216 · Phase: Not specified · Ages: 10 Years to 18 Years · Sex: Female · 1 location
• Gene Editing For Sickle Cell Disease
  NCT06506461 · Phase: Phase 1 · Ages: 18 Years to 24 Years · Sex: All (male and female) · 1 location
• Gene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)
  NCT05810181 · Phase: Not specified · Ages: 8 Years and older · Sex: All (male and female) · 1 location
• Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease
  NCT07616154 · Phase: Phase 2 · Ages: Up to 22 Years · Sex: All (male and female) · 1 location
• Investigation of the Genetics of Hematologic Diseases
  NCT02720679 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
  NCT07226219 · Phase: Phase 1 · Ages: 8 Years to 17 Years · Sex: All (male and female) · 1 location
• Molecular Analysis of Childhood and Adolescent Melanocytic Lesions
  NCT02775643 · Phase: Not specified · Ages: Up to 18 Years · Sex: All (male and female) · 1 location
• Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease
  NCT06477289 · Phase: Not specified · Ages: 12 Years to 25 Years · Sex: All (male and female) · 1 location
• Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET
  NCT05583721 · Phase: Phase 2 · Ages: 18 Years to 21 Years · Sex: All (male and female) · 1 location
• Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
  NCT07228741 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• SCD Stem Cell Mobilization and Apheresis Using Motixafortide
  NCT06442761 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• School Readiness Intervention for Preschool Children With Sickle Cell Disease
  NCT06367192 · Phase: Not applicable (e.g. observational or device study) · Ages: 42 Months to 78 Months · Sex: All (male and female) · 1 location
• Sickle Cell Clinical Research and Intervention Program
  NCT02098863 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 6 locations
• Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
  NCT04416178 · Phase: Not specified · Ages: 13 Years and older · Sex: All (male and female) · 1 location
• Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
  NCT04195347 · Phase: Phase 1, Phase 2 · Ages: Up to 21 Years · Sex: All (male and female) · 3 locations

Common questions

How many trials is St. Jude Children's Research Hospital recruiting for?

St. Jude Children's Research Hospital is the lead sponsor of 18 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.